Research has shown that IFIT3 is significantly elevated in monocytes from systemic lupus erythematosus (SLE) patients, where it is positively correlated with cGAS-STING pathway activity, highlighting its role in amplifying antiviral responses (25). Here, IFIT3 is linked to systemic lupus erythematosus.